Healthcare firms that got here up with efficient Covid-19 vaccines, therapies and assessments are seeing an enormous monetary payoff and are beginning to spend their money, whereas grappling with questions on whether or not the expansion is sustainable.
Firms together with Pfizer Inc. and Moderna Inc. up to now have reported at the very least $79 billion in mixed world gross sales of Covid-19 vaccines and coverings for 2021, in accordance with a Wall Avenue Journal evaluate of latest earnings experiences. Diagnostic gross sales even have been sturdy for firms together with Abbott Laboratories , which had $7.7 billion in Covid-19 take a look at gross sales final 12 months.